The BSE, founded in 1875, is Asia's oldest stock exchange — it started under a banyan tree on Dalal Street, where the bronze bull stands today.
The BSE, founded in 1875, is Asia's oldest stock exchange — it started under a banyan tree on Dalal Street, where the bronze bull stands today.
The BSE, founded in 1875, is Asia's oldest stock exchange — it started under a banyan tree on Dalal Street, where the bronze bull stands today.
Bhagiradha Chemicals & Industries Limited is an India-based company, which is engaged in manufacture of crop protection chemicals. The Company has a portfolio of 30 products spread across various insecticides, herbicides and fungicides and other intermediates. The Company…
Weekly engine runs — movement reflects the numbers, not analyst opinion.
A weak, stagnant business, reasonably priced — but flagged on governance.
BHAGIRADHA CHEM & INDS L is scored on the general / industrial framework. It keeps a thin 3.4% of every rupee of sales as net profit. Cash conversion lags the reported profit (CFO/PAT -2.91×) — worth a closer look. Free cash flow is worth about -9.9% of its market value.
Over the last 3 years revenue compounded at 2%/yr and profit at -26%/yr. Book value itself has compounded 31%/yr — the hallmark of a genuine compounder. Return on equity is a weak 3.8%. In the latest quarter profit grew 228% versus the prior quarter.
At 140× earnings, the stock sits at the 35th percentile of its own 3.6-year range — the middle of where it has historically traded. Today's price already implies ~30%/yr earnings growth sustained for a decade — a demanding bar. The forensic screen raises a red flag: Only ₹0.02 of cash per ₹1 profit over 4 years — earnings not converting to cash.
A plain-English restatement of the figures on this page — rules-based, for education and research context, not investment advice or a recommendation.
| Ratio | Company | Sector | Read |
|---|---|---|---|
| P/E | 92.43 | 24.55 | worse |
| P/B | 3.55 | 2.05 | worse |
| EV/EBITDA | 32.47 | — | — |
| ROE | 3.83 | 3.96 | worse |
| ROCE | 5.47 | 9.3 | worse |
| ROA | 2.05 | 4.18 | worse |
| Quick Ratio | 1.18 | 1.76 | worse |
| Peer | P/E | P/B | ROE |
|---|---|---|---|
| UPL | 20.9 | 1.3 | 5.4% |
| PI Industries | 30.0 | 2.3 | 7.7% |
| Sumitomo Chemical India | 29.3 | 4.4 | 15.1% |
2% CAGR — growing but slowly. Growth is accelerating — latest year outpaced the prior year's rate.
Revenue is outpacing profit (2% vs -26%) — costs are rising faster than the top line. The latest year saw a +31% swing — check if it's a one-off or structural.
Operating margin has compressed from 13% to 4% — costs or competition are eating into profitability. Interest or tax burden is shrinking — more of the operating profit is reaching the bottom line. Margins have declined for 3 consecutive years — watch for a structural cost problem.
ROE at 3% — modest; the capital isn't working hard. Capital efficiency declining — ROE down 12pp.
Profit grew faster than EPS (-26% vs -68%) — share dilution is eroding per-share value. -68% EPS CAGR — this is the rate at which each share's claim on earnings is compounding.
1 of 3 years had negative operating cash flow — profitability on paper may not translate to cash. Investing outflows exceed operating cash — the company relies on external funding to finance expansion.
When operating cash keeps pace with reported profit, earnings are cash-backed; a persistent shortfall is a quality flag.
Revenue rose 24% sequentially — momentum is building. Wide quarterly swings (42% spread) — likely seasonality, lumpy orders, or project-based revenue. Run-rate stepping up — recent quarters average 39% above earlier ones.
Profit jumped 228% QoQ — check if this is operating leverage or a one-off item. Quarterly net margins are expanding (4% → 7%) — profitability per rupee of revenue is improving.
How today's P/E compares to the stock's own historical range. Dashed line = the 3.6y median.
Promoters hold just 19.6% — widely held; sentiment-driven.
Produced by a rules-based engine over licensed exchange fundamentals — every sentence above is derived from the numbers shown, no analyst or AI opinion involved. Education and research context, not investment advice. We are not SEBI-registered as an Investment Adviser or Research Analyst.